Download 6th European Congress of Virology

6th
European Congress of Virology
Complete Preliminary Programme (ECV 2016))
Lecture/Event
13:00 – 13:30
Chairpersons
Opening Ceremony – Welcome Session
Hall 1 - 2.Floor
Klaus Überla, Erlangen, Germany
Olaf Degen, Hamburg, Germany
Antiviral drug development: Assessing the present, imagining the future
Don Ganem, Emeryville CA, USA
Strategies to manage herpesvirus drug-resistance
Graciela Andrei, Leuven, Belgium
Entry inhibition as a future therapeutic option to treat hepatitis B and
hepatitis D virus infection
Stephan Urban, Heidelberg, Germany
Long-acting injectables for HIV therapy and prevention
Paul Benn, London, UK
Coffee Break
Foyer D-G; Hall G, D and E - 2.Floor
Marcus Altfeld, Hamburg, Germany
Teunis B. Geijtenbeek, Amsterdam, The Netherlands
Keynote: How viruses usurp the host cellular machineries to evade innate
immune responses: The case of the restriction factor BST2/Tetherin and the
HIV-1 protein Vpu
Clarisse Berlioz-Torrent, Paris, France
Keynote: HIV-1 evades innate sensing by a novel RNA sensor in dendritic
cells
Teunis B.H. Geijtenbeek, Amsterdam, The Netherlands
Cytomegalovirus recruits the retromer complex to promote NEMO degradation by autophagy
Elena Muscolino, Hamburg, Germany
Human herpesvirus 6 downregulates the expression of activating ligands
during lytic infection to escape elimination by natural killer cells
Dominik Schmiedel, Jerusalem, Israel
Antiviral activity of the cGAS-STING pathway against hepatitis B virus
infection
Seung-Ae Yim, Strasbourg, France
Membranous fingerprinting of HIV-1 infected primary CD4+ T cells reveals
virus-mediated dysregulation of a putative NK cell receptor
Sandra Dehn, Tübingen, Germany
Michael H. Malim, London, UK
Julian Schulze zur Wiesch, Hamburg, Germany
Keynote: HIV restriction - striking early
Michael H. Malim, London, UK
Requirements for initiation factors in the translation of hepatitis C virus
Esther Gonzalez-Almela, Madrid, Spain
Identification of potent restriction factors of hepatitis C virus infection and
their contribution to viral species-tropism
Richard J. P. Brown, Hannover, Germany
Novel techniques for genome visualization reveal the fate of incoming
adenoviral genomes against nuclear antiviral factors
Tetsuro Komatsu, Bordeaux, France
The antiviral protein viperin targets tick-borne encephalitis virus replication
and assembly
Kirstin Vonderstein, Umeå, Sweden
13:30 – 14:00
Plenary Session 1:
The Future of
Antiviral Therapy
14:00 – 14:30
14:30 – 15:00
15:00 – 15:30
15:30 – 16:00
Chairpersons
16:00 – 16:30
16:00 – 18:00
WS1:
Innate Antiviral
Immunity and Viral
Immune Evasion
17:00 – 17:15
17:15 – 17:30
17:30 – 17:45
17:45 – 18:00
Chairpersons
16:00 – 16:30
16:30 – 16:45
16:45 – 17:00
16:00 – 18:00
Wednesday, 19th October
16:30 – 17:00
WS2:
Restriction Factors
of Viral Infection
17:00 – 17:15
17:15 – 17:30
17:30 – 17:45
17:45 – 18:00
Room
Hall 1 – 2. Floor
Time
Hall 1 – 2. Floor
Session
Hall F – 2. Floor
Period
13:30 – 15:30
Date
* subject to change
In vivo evasion of MxA reveals pandemic potential of emerging influenza A
viruses
Ebrahim Hassan, Freiburg, Germany
SMARCA2 the ATPase subunit of the chromatin remodeling BAF complex is
required for the antiviral activity of MxA
Alexandra Dudek, Freiburg, Germany
6th
European Congress of Virology
Session
Time
Lecture/Event
Chairpersons
Dimitri Lavillette, Shanghai, China
Urs Greber, Zurich, Switzerland
Keynote: Insights into principles of virus entry and uncoating
Urs Greber, Zurich, Switzerland
Native structure of a retroviral envelope protein and its conformational
change upon interaction with the target cell
Christiane Riedel, Vienna, Austria
Quantitative phospho-proteomics reveal new insights into signaling events
triggered by influenza A virus infection
Silke Stertz, Zurich, Switzerland
The cytoskeletal adaptor protein obscurin-like 1 interacts with L2 and is
required for HPV16 endocytosis
Elena Wüstenhagen, Mainz, Germany
The spike protein of the middle east respiratory syndrome coronavirus has
sialic acid binding activity
Ivy Widjaja, Utrecht, The Netherlands
Quantification of the binding forces of Dengue virus with cell receptors at a
single-virus level
Yueh-Hsin Ping, Taiwan, Republic of China
Switching to LAMP1 during cell entry of Lassa virus
Ron Diskin, Rehovot, Israel
Gabriella Campadelli-Fiume, Bologna, Italy
Vincent Parissi, Bordeaux, France
Keynote: Control of, and regulation by, the BKPyV miRNA
Michael J. Imperiale, Ann Arbor MI, USA
An enterovirus mutant that can replicate in the absence of replication
organelles
Frank van Kuppeveld, Utrecht, The Netherlands
Chikungunya trans-replication systems as tools to study the properties of
replicase proteins
Tania Quirin, Helsinki, Finland
Delineating the interplay between the PB2 protein of influenza A virus and
the host ubiquitin proteasome system
Elise Biquand, Paris, France
Is replication fidelity of influenza A viruses modulated by a proofreading
activity?
Marion Declercq, Paris, France
Single-molecule FISH reveals non-selective packaging of Rift Valley fever
virus genome segments
Paul Wichgers Schreur, Lelystad, The Netherlands
Usp7, an ubiquitin specific protease, interacts with Merkel Cell polyomavirus
large T-antigen and modulates viral DNA replication
Manja Czech-Sioli, Hamburg, Germany
16:00 – 16:30
16:00 – 18:00
16:30 – 16:45
16:45 – 17:00
WS3:
Virus Attachment
and Entry
17:00 – 17:15
17:15 – 17:30
17:45 – 18:00
Chairpersons
16:00 – 16:30
16:30 – 16:45
16:45 – 17:00
16:00 – 18:00
Wednesday, 19th October
17:30 – 17:45
WS4:
Virus Replication
Strategies
17:00 – 17:15
17:15 – 17:30
17:30 – 17:45
17:45 – 18:00
18:15 – 19:00
ESV Junior Investigator Award
18:00 – 20:00
Poster Session – Scientific Networking
Room
Hall A – 1. Floor
Period
Hall B – 1. Floor
Date
* subject to change
Hall 1 –
2. Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
Session
Time
Lecture/Event
Chairpersons
Thomas Harrer, Erlangen, Germany
Julian Schulze zur Wiesch, Hamburg, Germany
Keynote: Mechanisms of HIV pathogenesis and HIV cure – insights from the
paediatric HIV infection
Philip Goulder, Oxford, UK
Protein carbamoylation increases the restimulation of pp65-specific T cells in
vitro
Ralf Wagner, Regensburg, Germany
Specificity and phenotype of T cells in primary human cytomegalovirus
infection in pregnancy
Daniele Lilleri, Pavia, Italy
Sequence-function analysis of three T-cell receptors targeting the HIV-1 p17
epitope SLYNTVATL
Christiane Mummert, Erlangen, Germany
An immune-competent inbred mouse model of HCV-related rodent hepacivirus infection
Eva Billerbeck, New York City NY, USA
Identification of novel MHC I and MHC II restricted hepatitis D virus-specific
peptide epitopes
Johanna Blöcker, Hamburg, Germany
Analysis of the adaptive cellular immune response to Nipah virus-like particles in C57BL/6 and Balb/c mice
Sandra Diederich, Greifswald - Insel Riems, Germany
Hans-Georg Kräusslich, Heidelberg, Germany
Beate Sodeik, Hannover, Germany
Keynote: Herpesvirus nuclear egress – elucidation of the prototypic vesicular
nucleo-cytoplasmic transport
Thomas Mettenleiter, Greifswald – Insel Riems, Germany
Keynote: Host-catalyzed capsid assembly modulation: A new approach to
anti-viral drug discovery
Vishwanath R. Lingappa, San Francisco CA, USA
A secretory pathway calcium ATPase regulates viral spread by modulating
cellular proteolysis
Hans-Heinrich Hoffmann, New York City NY, USA
Incorporation of the influenza A virus NA segment does not require homologous non-coding sequences
Sylvie van der Werf, Paris, France
Proteomics of HCV virions reveals a surprising role for the nucleoporin
Nup98 in virus morphogenesis
Maria Teresa Catanese, London, UK
Role of Rab33B and its autophagic Atg5/12/16L1 effector in hepatitis B virus
morphogenesis
Christina Bartusch, Mainz, Germany
Elisabeth Puchhammer, Vienna, Austria
René A.A. van der Vlugt, Wageningen, The Netherlands
Keynote: Prospects for digital PCR in viral diagnostics
Ward De Spiegelaere, Ghent, Belgium
Infectious Laryngotracheitis virus (ILTV) vaccine intake evaluation by detection of virus amplification in feather pulps of vaccinated chickens
Irit Davidson, Bet Dagan, Israel
Influence of glycoprotein C on Bovine Herpesvirus-1 virion composition and
implications for diagnostics
Susanne Koethe, Greifswald - Insel Riems, Germany
The immunoglobulin-like domain of HsFcµR (TOSO, FAIM3) binds IgM/
antigen immune complexes and can be used as a novel capture molecule in
serological tests
Christina Deschermeier, Hamburg, Germany
08:30 – 09:00
08:30 – 10:30
09:00 – 09:15
09:15 – 09:30
WS5:
Adaptive Antiviral
Immunity and Viral
Immune Evasion
09:30 – 09:45
09:45 – 10:00
10:00 – 10:15
Chairpersons
08:30 – 09:00
08:30 – 10:30
09:00 – 09:30
WS6:
Virus Maturation
and Egress
09:30 – 09:45
09:45 – 10:00
10:00 – 10:15
10:15 – 10:30
Chairpersons
08:30 – 09:00
08:30 – 10:30
Thursday, 20th October
10:15 – 10:30
09:00 – 09:15
WS7:
Advanced Virus
Diagnosis
09:15 – 09:30
09:30 – 09:45
Room
Hall 1 – 2. Floor
Period
Hall F – 2. Floor
Date
* subject to change
Hall A – 1. Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
WS7:
Advanced Virus
Diagnosis
Time
Lecture/Event
09:45 – 10:00
Development of ELISA for detection of Seneca Valley virus exposure
Zeynep Akkutay-Yoldar, Ankara, Turkey
NS1-based anti-Zika virus ELISA revealed no cross-reactivity with other flavivirus infections or vaccination
Katja Steinhagen, Lübeck, Germany
Clinical evaluation of the Veris HCV assay for hepatitis C virus RNA quantification
Laure Izquierdo, Villejuif, France
Giorgio Palù, Padova, Italy
Maria G. Masucci, Stockholm, Sweden
Keynote: Viral interference with ubiquitin and UbL-regulated signaling
pathways
Maria G. Masucci, Stockholm, Sweden
Th17, CCR6+ cells lack RNAses and are highly permissive to HIV infection:
Implications for pathogenesis and therapy
Alfredo Garzino Demo, Padova, Italy
Bio-imaging of alphaviral disease in mice: A study using Ross River virus
Essia Belarbi, Fontenay aux Roses, France
Comparative analysis between flaviviruses reveals specific neural stem cell
tropism for Zika virus in the mouse developing neocortex
Cecile Khou, Paris, France
Susceptibility and inflammatory response of human neural cells to Zika virus
and West Nile virus infection
Giovanna Desole, Padova, Italy
Transcriptome analysis of human fetal astrocytes infected with Zika virus
reveals dysregulation of genes required for brain development
Daniel Limonta, Edmonton, Canada
Pathogenesis of Zika virus infection in a non-human primate model
Patricia Pesavento, Davis CA, USA
10:00 – 10:15
10:15 – 10:30
Chairpersons
08:30 – 09:00
08:30 – 10:30
09:15 – 09:30
WS8:
Viral Pathogenesis
09:30 – 09:45
09:45 – 10:00
10:00 – 10:15
10:15 – 10:30
10:30 – 11:00
Chairpersons
11:00 – 11:30
11:00 – 13:00
Thursday, 20th October
09:00 – 09:15
Plenary Session 2:
Animal Models for
Virus Research
11:30 – 12:00
12:00 – 12:30
12:30 – 13:00
13:00 – 15:00
Satellite
Symposium
13:15 – 14:15
Room
Hall A – 1. Floor
Session
Coffee Break
Foyer D-G; Hall G, D and E - 2.Floor
Marc Lütgehetmann, Hamburg, Germany
Cesar Muñoz-Fontela, Hamburg, Germany
Animal models to assess efficacy of infectious disease intervention:
Ebola, CCHR and Influenza
Miles W. Carroll, Salisbury, UK
Human tumor virus infection and immune control in vivo
Christian Münz, Zurich, Switzerland
Animal models of viral hepatitis
Alexander Ploss, Princeton NJ, USA
Humanized mouse models for the study of viral pathogens and persistence
J. Victor Garcia, Chapel Hill NC, USA
Lunch Break
Foyer D-G; Hall G, D and E - 2.Floor
Hall 1 – 2. Floor
Period
QIAGEN-Symposium:
“Novel Technologies for Improved Pathogen Detection“
Hall F –
2. Floor
Date
* subject to change
Hall B – 1. Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
Session
Time
Lecture/Event
Chairpersons
Florian Klein, Cologne, Germany
Alexandra Trkola, Zurich, Switzerland
Keynote: Virus, host and disease factors govern HIV-1 broadly neutralizing
antibody induction
Alexandra Trkola, Zurich, Switzerland
Long-term immunogenicity of bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programs
Luisa Barzon, Padova, Italy
Association of human IgG1 heavy chain variants on neutralization capacity
and antibody dependent cellular cytotoxicity against HCMV
Hannes Vietzen, Vienna, Austria
HIV Env antibody can provide sterilizing immunity in the strictest sense
Klaus Überla, Erlangen, Germany
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza
protection
Hadi Yassine, Doha, Qatar
Structural basis of Zika virus cross-reactivity and cross-neutralization with
flavivirus post-infection and post-vaccination sera
Karin Stiasny, Vienna, Austria
Experimental infection of horses with nonprimate hepacivirus mediates
immune protection against re-infection
Stephanie Pfänder, Hannover, Germany
Félix A. Rey, Paris, France
Kay Grünewald, Hamburg, Germany
Keynote: The structurally identified homology between viral and cellular
membrane fusion proteins highlights the impact of genetic exchanges
during evolution
Félix A. Rey, Paris, France
Flying viruses – from biophysical to structural characterisation
Charlotte Uetrecht, Hamburg, Germany
Live cell dynamics of herpesvirus nuclear egress
Jens Bosse, Hamburg, Germany
Cellular microtubule scaffold promotes efficient assembly and genome
packaging of the non-enveloped virus reovirus
Pranav Shah, Heidelberg, Germany
Aggregates or virus-like particles? Ordered structure of isolated matrix
protein M1 revealed by SAXS and AFM
Eleonora Shtykova, Moscow, Russian Federation
Acidic pH-induced conformation and LAMP1 inding of the lassa virus glycoprotein spike
Sai Li, Oxford, UK
Nucleic acid binding motif in capsid protein of Mason-Pfizer monkey virus
Pavel Ulbrich, Prague, Czech Republic
Hans-Jürgen Stellbrink, Hamburg, Germany
Jürgen Rockstroh, Bonn, Germany
Keynote: Approved antivirals for HIV, HBV and HCV:
What has been achieved, what are the remaining challenges?
Jürgen Rockstroh, Bonn, Germany
Keynote: Presence and future of HEV treatment options
Sven Pischke, Hamburg, Germany
Acute hepatitis E in patients with gynecological malignancy – a case series
Stefan Schlabe, Bonn, Germany
In silico evaluation of Oseltamivir treatment strategies against Influenza –
Pneumococcus coinfection
Alessandro Boianelli, Braunschweig, Germany
15:00 – 15:30
15:00 – 17:00
15:30 – 15:45
15:45 – 16:00
WS9:
Humoral Immune
Response to Viral
Infection
16:00 – 16:15
16:15 – 16:30
16:30 – 16:45
Chairpersons
15:00 – 15:30
15:00 – 17:00
15:30 – 15:45
15:45 – 16:00
WS10:
Virus Structure and
Imaging
16:00 – 16:15
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
Chairpersons
15:00 – 15:30
15:00 – 16:30
Thursday, 20th October
16:45 – 17:00
WS11:
Approved Antiviral
Therapies
15:30 – 16:00
16:00 – 16:15
16:15 – 16:30
Room
Hall 1 – 2. Floor
Period
Hall F – 2. Floor
Date
* subject to change
Hall A – 1. Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
Session
Time
Lecture/Event
Chairpersons
Dana Wolf, Jerusalem, Israel
Annette Haberl, Frankfurt, Germany
Keynote: Congenital human cytomegalovirus transmission and pathogenesis: From epidemiology to experimental modeling
Dana Wolf, Jerusalem, Israel
Differential diagnosis of respiratory and enteric viral infections in children
Aleksandra Nikonova, Moscow, Russian Federation
Discovery of a potent, M2-1-targeting inhibitor of human respiratory syncytial
virus infection in vivo
Benjamin Bailly, Gold Coast, Australia
Repurposing suramin and zanamivir into a synergistic combination that
blocks human parainfluenza type-3 virus infection
Benjamin Bailly, Gold Coast, Australia
Vaccine effectiveness and genetic diversity in the context of increasing
immunization rates against Rotavirus infections
Corinna Pietsch, Leipzig, Germany
Universal neonatal Cytomegalovirus screening using saliva:
Report of an experience in an Italian center
Andrea Busni, Brescia, Italy
Development of a murine model of Enterovirus 71 (EV71) infection, disease,
and pathology using mouse-cell-adapted strains
Carla B. L. Victorio, Singapore, Singapore
15:00 – 15:30
15:30 – 15:45
WS12:
Pediatric Viral
Infections
15:00 – 17:00
Thursday, 20th October
15:45 – 16:00
16:00 – 16:15
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
17:15 – 18:00
EVA – European Virology Award
17:30 – 19:30
Poster Session – Scientific Networking
from 18:30
ESV – Executive Board and Advisory Council Meeting
Room
Hall B – 1. Floor
Period
Hall 1 –
2. Floor
Date
* subject to change
Hall C –
1. Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
Session
Time
Lecture/Event
Chairpersons
Ralf Wagner, Regensburg, Germany
Giuseppe Pantaleo, Lausanne, Switzerland
Keynote: HIV vaccine: Myth or reality?
Giuseppe Pantaleo, Lausanne, Switzerland
rVSV-platform: Immunogenicity data against the vector and insert of rVSVZEBOV in healthy adults – a phase I study
Christine Dahlke, Hamburg, Germany
Vaccine generation against gamma herpesvirus infection in a murine
surrogate model
Baila Samreen, Düsseldorf, Germany
Efficient immunization and full protection from lethal challenge by DNA-YFVax, a novel thermostable and readily scalable plasmid-launched live-attenuated yellow fever vaccine candidate produced in E. coli
Kai Dallmeier, Leuven, Belgium
Triterpen saponins of plant origin incorporated into saponin/lipid nanoparticles as an efficient adjuvant system for mucosal immunization
Vladimir Berezin, Almaty, Kazakhstan
Modified vaccinia virus based vaccine protection against MERS-CoV
infection in dromedary camels
V. Stalin Raj, Rotterdam, The Netherlands
Pathogens inactivated by low-energy-electron irradiation maintain antigenic
properties and induce protective immune responses
Jasmin Fertey, Leipzig, Germany
Thomas Mettenleiter, Greifswald – Insel Riems, Germany
Wim H. van der Poel, Wageningen, The Netherlands
Keynote: Emerging topics at issue in veterinary virology
Wim H. van der Poel, Wageningen, The Netherlands
Full-genome based molecular characterization of encephalitis-associated
bovine astroviruses
Torsten Seuberlich, Bern, Switzerland
Newly discovered polyomaviruses in animals: Uncovering causality
Patricia Pesavento, Davis CA, USA
Macrophages from pigs lacking the SRCR5 domain of CD163 are resistant to
porcine reproductive and respiratory syndrome virus infection
Christine Burkard, Roslin, UK
Virus-host interactome high-throughput mapping: From the identification of
new factors of pathogenicity and interspecies transmission to new therapeutic targets for an animal arbovirus
Grégory Caignard, Maisons-Alfort, France
Immunogenicity and protective efficacy of recombinant Modified Vaccinia
virus Ankara candidate vaccines delivering West Nile virus envelope antigens
vaccine
Asisa Volz, Munich, Germany
Novel variant of porcine epidemic diarrhea virus in England detected
through archive mining
Falko Steinbach, Addlestone, UK
Thomas Dobner, Hamburg, Germany
Massimo Tommasino, Lyon, France
Keynote: Novel insights into viral-mediated tumorigenesis
Susanna Chiocca, Milano, Italy
Keynote: Oncogenic viruses and more: Impact on host pathways and
cooperation with environmental factors
Massimo Tommasino, Lyon, France
08:30 – 09:00
09:00 – 09:15
08:30 – 10:30
09:15 – 09:30
WS13:
Antiviral Vaccines
09:30 – 09:45
09:45 – 10:00
10:00 – 10:15
Friday, 21st October
10:15 – 10:30
Chairpersons
08:30 – 09:00
09:00 – 09:15
08:30 – 10:30
09:15 – 09:30
09:30 – 09:45
WS14:
Emerging Topics in
Veterinary Virology
09:45 – 10:00
10:00 – 10:15
10:15 – 10:30
08:30 – 10:30
Chairpersons
WS15:
Oncogenic
Mechanisms of
Viruses
08:30 – 09:00
09:00 – 09:30
Room
Hall 1 – 2. Floor
Period
Hall F – 2. Floor
Date
* subject to change
Hall A – 1. Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
Complete Preliminary Programme (ECV 2016))
Lecture/Event
09:30 – 09:45
Human papillomavirus oncogenes contribute to acquisition of stem cell
ability in vitro
Katerina Strati, Nicosia, Cyprus
PTPN14 is a novel degradation target of human papillomavirus E7 oncoprotein
Anita Szalmas, Debrecen, Hungary
Interaction of the Merkel Cell polyomavirus LT-antigen with host cell
chromatin
Juliane Theiss, Hamburg, Germany
Establishment of a human adult stem cell model to understand the role of
EBV oncogenic mechanisms in epithelial malignancies
Wilhelm Ching, Hamburg, Germany
Bernhard Fleckenstein, Erlangen, Germany
Carmen Rivas, Madrid, Spain
Keynote: Targeting of cellular SUMO-regulated pathways by KSHV latent
protein LANA2
Carmen Rivas, Madrid, Spain
Classical swine fever virus generate superinfection exclusion at the organism
level in swine
Llilianne Ganges, Barcelona, Spain
Parvovirus B19 persists in tonsillar B cells
Mari Toppinen, Helsinki, Finland
Humanized mice to study acute and persistent human adenovirus infections
Estefania Rodriguez, Hamburg, Germany
Generation of human peripheral neurons to study Varicella Zoster virus
latency, reactivation and induction of pain
Abel Viejo-Borbolla, Hannover, Germany
Analyzing mechanisms of KSHV latency and intervention using novel in vitro
and in vivo models
Tatyana Dubich, Braunschweig, Germany
BRD2/4-mediated chromatin association of LANA is important for latent
persistence of KSHV
Rishikesh Lotke, Hannover, Germany
Coffee Break
Foyer D-G; Hall G, D and E – 2.Floor
Marylyn M. Addo, Hamburg, Germany
Denis Fargette, Montpellier, France
Filovirus infections in bats and humans
Jonathan Towner, Atlanta GA, USA
Emerging viral infections: The power of deep sequencing
Martin Beer, Greifswald - Insel Riems, Germany
Biogeography of viral emergence: Rice yellow mottle virus as a case study
Denis Fargette, Montpellier, France
Emerging viruses in the Balkan and Mediterranean region
Anna Papa, Thessaloniki, Greece
Lunch Break
Foyer D-G; Hall G, D and E – 2.Floor
09:45 – 10:00
WS15:
Oncogenic
Mechanisms of
Viruses
10:00 – 10:15
10:15 – 10:30
Chairpersons
08:30 – 10:30
09:00 – 09:15
09:15 – 09:30
WS16:
Viral Latency and
Persistence
09:30 – 09:45
09:45 – 10:00
10:00 – 10:15
10:15 – 10:30
10:30 – 11:00
Chairpersons
11:00 – 13:00
Friday, 21st October
08:30 – 09:00
11:00 – 11:30
Plenary Session 3:
Emerging Virus
Infections
11:30 – 12:00
12:00 – 12:30
12:30 – 13:00
13:00 – 15:00
Satellite
Symposium
13:15 – 14:45
Room
Hall A – 1. Floor
Time
Hall B – 1. Floor
Session
Hall 1 – 2. Floor
Period
ANRS / DZIF Symposium:
“HBV and HIV Cure“
Hall F –
2. Floor
Date
* subject to change
6th
European Congress of Virology
Session
Time
Lecture/Event
Chairpersons
Ben Berkhout, Amsterdam, The Netherlands
Ralf Bartenschlager, Heidelberg, Germany
Keynote: From oncolytic virotherapy to oncolytic immunotherapy
Gabriella Campadelli-Fiume, Bologna, Italy
Keynote: Antiviral therapy of chronic hepatitis C: Remaining challenges and
new opportunities
Ralf Bartenschlager, Heidelberg, Germany
Polo-like-kinase 1 is a proviral host-factor for hepatitis B virus replication and
a target for combined antiviral strategies
David Durantel, Lyon, France
Characterization of a novel human monoclonal antibody targeting the
hepatitis C virus envelope protein
Ahmed Atef Mesalam, Ghent, Belgium
Humanization of a claudin-1-specific monoclonal antibody to prevent and
cure HCV infection without escape
Che C. Colpitts, Strasbourg, France
A phase 1, open label, dose-escalation study of the safety, pharmacokinetics
and antiretroviral activity of 10-1074 monoclonal antibody in HIV-infected
and HIV-uninfected individuals
Till Schoofs, New York City NY, USA
Stefan Günther, Hamburg, Germany
Heinz Feldmann, Hamilton MT, USA
Keynote: Vaccine approaches for highly pathogenic viruses
Heinz Feldmann, Hamilton MT, USA
Interference of MERS-CoV accessory genes with the innate immune
response and their contribution to virulence
Isabel Sola, Madrid, Spain
Role of SARS-CoV viroporins E, 3a, and 8a in virus replication and virulence:
Complementation between the PBMs of E and 3a proteins
Carlos Castaño-Rodríguez, Madrid, Spain
Immune markers of fatal human Ebola virus disease
Paula Ruibal, Hamburg, Germany
Regulation of Ebola virus matrix protein VP40 by SUMO
Maite Baz-Martínez, Santiago de Compostela, Spain
Efficacy of Favipiravir and Ribavirin in a novel mouse model of Lassa fever
Lisa Oestereich, Hamburg, Germany
HPAIV H5 evolution requires adaptation of the hemagglutinin by elevation of
the fusion competence activation pH
Jürgen Stech, Greifswald – Insel Riems, Germany
Wolfram Brune, Hamburg, Germany
Bryan R. Cullen, Durham NC, USA
Keynote: Post-transcriptional regulation of viral gene expression
Bryan R. Cullen, Durham NC, USA
A broad RNA virus survey identifies the miR-17 family as a critical host factor
for pestiviruses
Troels K. H. Scheel, Copenhagen, Denmark
An unprecedented protein-stimulated -2/-1 ribosomal frameshift mechanism
in arteriviruses
Eric Snijder, Leiden, The Netherlands
A systematic view on influenza induced host shut-off
Julie Tai, Rehovot, Israel
Novel preferences in influenza A virus cap-snatching
Zuleyma Peralta, New York City NY, USA
Spatiotemporal analysis of global protein synthesis and PML domains
association during HSV infection revealed by click chemistry
Su Hui Catherine Teo, London, UK
Cardiotonic steroids suppress adenovirus replication
Martha Brown, Toronto, Canada
15:00 – 15:30
15:00 – 17:00
15:30 – 16:00
16:00 – 16:15
WS17:
Experimental Antiviral Therapies
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
Chairpersons
15:00 – 17:00
15:30 – 15:45
15:45 – 16:00
WS18:
Highly Pathogenic
Viruses
16:00 – 16:15
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
Chairpersons
15:00 – 15:30
15:30 – 15:45
15:00 – 17:00
Friday, 21st October
15:00 – 15:30
WS19:
Viral Gene
Expression –
Transcription,
Translation
15:45 – 16:00
16:00 – 16:15
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
Room
Hall 1 – 2. Floor
Period
Hall F – 2. Floor
Date
* subject to change
Hall A – 1. Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
Session
Time
Lecture/Event
Chairpersons
Gerd Sutter, Munich, Germany
Peter Liljeström, Stockholm, Sweden
Keynote: RNA replicon vaccines
Peter Liljeström, Stockholm, Sweden
Development of MVA-MERS-S for phase I clinical evaluation:
A candidate vaccine against Middle East Respiratory Syndrome coronavirus
Asisa Volz, Munich, Germany
Clonal Oka varicella vaccine variants with reduced viral genome size and
presumed higher clinical safety
Husam Taher, Kiel, Germany
Development of an artificial reassortant of Infectious Salmon Anaemia Virus
(ISAV) with reverse genetic system: The solution for a new vaccine against
uncultivable HPR0 genotype strains
Marcelo Cortez-San Martín, Santiago de Chile, Chile
The viral vector vaccine VSV-GP as vaccine platform
C. Anika Bresk, Innsbruck, Austria
Priming with a potent HIV-1 DNA vaccine frames the quality of T cell and
antibody responses prior to a poxvirus and protein boost
Benedikt Asbach, Regensburg, Germany
Integrative approaches towards the generation of a synthetic polio vaccine
Mohammad W. Bahar, Oxford, UK
15:00 – 15:30
15:00 – 17:00
Friday, 21st October
15:30 – 15:45
15:45 – 16:00
WS20:
Viral Vectors for
Vaccine Design
16:00 – 16:15
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
17:15 – 19:00
General Assembly – ESV
17:15 – 19:00
Poster Session – Scientific Networking
19:00 – 00:00
Congress Dinner & Networking Event
Room
Hall B - 1. Floor
Period
Hall 1 –
2. Floor
Date
* subject to change
Hall 3 –
Ground
Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
Session
Time
Lecture/Event
Chairpersons
Todd Allen, Cambridge MA, USA
Rolf Kaiser, Cologne, Germany
Keynote: HIV resistance testing from 1999 to 2016 and beyond
Rolf Kaiser, Cologne, Germany
Characterisation of longitudinal human cytomegalovirus genome diversity by
next generation sequencing of blood samples from immunocompromised
patients suggests turnover of viral strains
Elias Hage, Hannover, Germany
PatchDetection: Inference of (seasonally) reoccurring patterns of patches
under positive selection in human influenza A/H3N2 viruses
Thorsten R. Klingen, Braunschweig, Germany
Differences among mumps virus surface proteins between genotype G and
other genotypes at sites important for immunity and pathogenesis
Tessa Vermeire, Ukkel, Belgium
Use of Ebola pseudoviruses to interrogate the impact of Ebolavirus
glycoprotein evolution during the West African outbreak
Richard A. Urbanowicz, Nottingham, UK
Fitness changes and mutation dynamics in evolved hepatitis C virus populations in the cell culture system
Elena Moreno del Olmo, Madrid, Spain
Ribavirin-induced mutagenesis of the hepatitis E virus genome in vivo
Daniel Todt, Hannover, Germany
Marion Koopmans, Rotterdam, The Netherlands
Christian Drosten, Bonn, Germany
Keynote: MERS – a classical zoonosis with a pre-pandemic implication
Christian Drosten, Bonn, Germany
08:30 – 09:00
08:30 – 10:30
09:00 – 09:15
09:15 – 09:30
WS21:
Viral Evolution and
Resistance
09:30 – 09:45
09:45 – 10:00
10:00 – 10:15
Chairpersons
08:30 – 09:00
09:00 – 09:15
08:30 – 10:30
09:15 – 09:30
WS22:
Virus Epidemiology
and Surveillance
09:30 – 09:45
09:45 – 10:00
10:00 – 10:15
10:15 – 10:30
Chairpersons
08:30 – 09:00
08:30 – 10:30
Saturday, 22nd October
10:15 – 10:30
WS23:
Infection of the
Immunocompromised
09:00 – 09:15
09:15 – 09:30
09:30 – 09:45
Seasonality and selective trends in viral acute respiratory tract infections
Patrick Shaw Stewart, Hungerford, UK
Emergence of highly pathogenic H5Nx influenza A viruses is accompanied
with a change in H5 receptor-binding specificity
Erik de Vries, Utrecht, The Netherlands
Ebola virus disease: Epidemiological modelling and impacts of vaccination
and other measures to improve survival
Che Ismail Che Noh, Kota Kinabalu, Malaysia
MERS update in Saudi Arabia and probable future outbreaks
Islam Nour, Riyadh, Saudi Arabia
Epidemiology of the four human coronavirus 229E, HKU1, NL63, and OC43
detected over two years in hospitalized adult patients
Giuseppe Paganini, Brescia, Italy
Targeted enrichment of viral DNA in soft tissues from 300-year-old mummies
from Lithuania
Klaus Hedman, Helsinki, Finland
Thomas Schulz, Hannover, Germany
Hans Hirsch, Basel, Switzerland
Keynote: Immune responses in replicative and non-replicative virus pathology: What we can we learn from polyomaviruses
Hans Hirsch, Basel, Switzerland
The challenges of data robustness in sequencing complete human cytomegalovirus genomes directly from clinical material
Nicolas Suarez, Glasgow, UK
Are human myeloid dendritic cells hijacked by the BK polyomavirus?
Mathieu Sikorski, Nantes, France
Role of neutralizing antibodies in the control of BK polyomavirus reactivation
in kidney transplant recipients
Dorian Mcilroy, Nantes, France
Room
Hall 1 – 2. Floor
Period
Hall F – 2. Floor
Date
* subject to change
Hall A – 1. Floor
Complete Preliminary Programme (ECV 2016))
6th
European Congress of Virology
Complete Preliminary Programme (ECV 2016))
Lecture/Event
09:45 – 10:00
Survival and immunological improvement of ART-naïve HIV patients by HPgV
coinfection
Gibran Horemheb-Rubio, Mexico City, Mexico
Immune reconstitution hepatitis A in a patient with AIDS demonstrates the
importance of immunopathology
Thomas Harrer, Erlangen, Germany
Hepatitis E at a tertiary center in Northern Germany
Dirk Westhölter, Hamburg, Germany
Gülsah Gabriel, Hamburg, Germany
Noël Tordo, Paris, France
Keynote: Ebola and Rabies, bats and dogs: Differences and similarities
between two zoonoses, applicability of the “One Health“ concept
Noël Tordo, Paris, France
The sialic acid binding preference determines the differential interaction
between influenza A viruses and streptococci
Jie Tong, Hannover, Germany
The neuraminidase protein of novel H7N9 virus displays reduced enzymatic
activity resulting from mutation of the 2nd sialic acid binding site
Meiling Dai, Utrecht, The Netherlands
Host-symbionts interaction driving evolution of alpha and beta coronaviruses
(CoVs) in their bat hosts
Stefania Leopardi, Legnaro, Italy
Bat coronaviruses in France and Western Palearctic: After MERS-CoV and
SARS-CoV, are there other candidates to emergence?
Meriadeg Ar Gouilh, Paris, France
Stem cell-derived hepatocellular systems for the study of genuine pangenotype hepatitis E virus replication
Viet Loan Dao Thi, New York City NY, USA
PTLV-1 among humans in two regions of tropical Africa
Grit Schubert, Berlin, Germany
Coffee Break
Foyer D-G; Hall G, D and E – 2.Floor
10:00 – 10:15
10:15 – 10:30
Chairpersons
08:30 – 09:00
08:30 – 10:30
09:00 – 09:15
09:15 – 09:30
WS24:
Zoonotic Viruses
09:30 – 09:45
Saturday, 22nd October
09:45 – 10:00
10:00 – 10:15
10:15 – 10:30
10:30 – 11:00
Chairpersons
11:00 – 13:00
11:00 – 11:30
Plenary Session 4:
Next Generation
Viromics
11:30 – 12:00
12:00 – 12:30
12:30 – 13:00
Adam Grundhoff, Hamburg, Germany
Albert Osterhaus, Hannover, Germany
Virus genome variation in infected individuals and populations
Paul Kellam, Cambridge, UK
The merging of fields through NGS applications in emerging infectious
diseases
Marion Koopmans, Rotterdam, The Netherlands
Viral signatures of immune control of HIV and HCV
Todd Allen, Cambridge MA, USA
Virus discovery in human and animals: From genomes to diseases
Eric Delwart, San Francisco CA, USA
Lunch Break
Foyer D-G; Hall G, D and E – 2.Floor
Satellite
Symposium
13:15 – 14:45
Erasmus MC / Institut Pasteur Symposium:
“Emerging Zoonoses“
Satellite
Symposium
13:15 – 14:45
ESV – Symposium:
“Challenges in Clinical Virology”
Hall F –
2. Floor
Ulrike C. Lange, Hamburg, Germany
Thomas F. Baumert, Strasbourg, France
Keynote: Cell circuits of viral entry, disease biology and antiviral therapy
Thomas F. Baumert, Strasbourg, France
Keynote: Genome editing as antiviral therapy
Frank Buchholz, Dresden, Germany
Hall 1 –
2. Floor
15:00 – 17:00
13:00 – 15:00
Room
Hall A – 1. Floor
WS23:
Infection of the
Immunocompromised
Time
Hall B – 1. Floor
Session
Hall 1 – 2. Floor
Period
Hall A –
1. Floor
Date
* subject to change
Chairpersons
WS25:
Curative Strategies
for Virus Eradication
15:00 – 15:30
15:30 – 16:00
6th
European Congress of Virology
Lecture/Event
16:00 – 16:15
Novel targets for potent antiviral drugs: The development of Pritelivir and
Letermovir against viruses from the herpes group
Helga Rübsamen-Schaeff, Frankfurt, Germany
Antiviral effects of zinc oxide (ZnO) nanoparticles against H1N1 (pdm09)
Rishikesh Kumar, Patna, India
Natural humic substances interfere with multiple stages of the replication
cycle of human immunodeficiency virus
Yury Zhernov, Moscow, Russian Federation
Antiviral activity of apigenin against African swine fever virus
Hovakim Zakaryan, Yerevan, Armenia
Nicole Fischer, Hamburg, Germany
Eric Delwart, San Francisco CA, USA
Keynote: Animal viruses leaving the animal-human interface
Albert Osterhaus, Hannover, Germany
Polymycoviridae: An emerging family of mycoviruses
Ioly Kotta-Loizou, London, UK
Discovery and characterization of a new avian hepatitis B virus in a palaeognath bird
Wendy K. Jo, Hannover, Germany
Co-circulation of potentially novel paramyxoviruses in bats in Central Brazi
William Marciel Souza, Ribeirão Preto, Brazil
Investigation of hantavirus prevalence in wild rodent population in the
United Kingdom
Joe Chappell, Nottingham, UK
Sero- and genoepidemiology of two human protoparvoviruses, bufavirus
and tusavirus
Elina Väisänen, Helsinki, Finland
HERV-W group evolutionary history: Characterization of the group in nonhuman primates and identification of highly related sequences in new world
monkeys
Nicole Grandi, Cagliari, Italy
Daniel Cadar, Hamburg, Germany
Stéphane Blanc, Montpellier, France
Keynote: Vector transmission: Commonalities and specificities in plant and
animal viruses
Stéphane Blanc, Montpellier, France
Keynote: Zika virus pathogenesis
Helen Lazear, Chapel Hill NC, USA
Mosquito-specifc bunyaviruses
Ingeborg van Knippenberg, Glasgow, UK
Mosquito saliva increases endothelial permeability in the skin, immune cell
migration and dengue pathogenesis during antibody-dependent enhancement
Michael A. Schmid, Berkeley CA, USA
Alpha-repeat molecules as novel antivirals against flaviviruses by targeting
the envelope glycoprotein and the NS1 protein
Wilhelm Furnon, Lyon, France
Antiviral piRNA pathway in the arbovirus vector Aedes aegypti
Margus Varjak, Glasgow, UK
Julian Schulze zur Wiesch, Hamburg, Germany
Karin Mölling, Berlin, Germany
Short presentations selected from Poster Sessions
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
Chairpersons
15:00 – 15:30
15:30 – 15:45
15:00 – 17:00
WS26:
Virus Discovery, Typing and
Metagenomics
16:00 – 16:15
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
Chairpersons
15:00 – 17:00
15:00 – 15:30
15:30 – 16:00
WS27:
Vector Borne Infections
16:00 – 16:15
16:15 – 16:30
16:30 – 16:45
16:45 – 17:00
15:00 – 17:00
Saturday, 22nd October
15:45 – 16:00
WS28:
Best of Posters
Chairpersons
15:00 – 17:00
17:15 – 18:00
Life Science Nord – Poster Prize
Farewell – Next Meeting Presentation
Room
Hall 1 – 2. Floor
WS25:
Curative Strategies
for Virus
Eradication
Time
Hall F – 2. Floor
Session
Hall A – 1. Floor
Period
Hall B –
1. Floor
Date
* subject to change
Hall 1 –
2.Floor
Complete Preliminary Programme (ECV 2016))